ArticlePloS one2025

Post-marketing safety of solriamfetol: A retrospective pharmacovigilance study based on the us food and drug administration adverse event reporting system.

Lingling Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.